AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Zealand Pharma

Director's Dealing Apr 19, 2023

3391_rpt_2023-04-19_7e539592-a092-4303-953f-708e2d0d1fa9.pdf

Director's Dealing

Open in Viewer

Opens in native device viewer

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1. Details of the person discharging managerial responsibilities/person closely associated
a) Name Louise Gjelstrup
2. Reason for the notification
a) Position/status Employee elected member of the Board of Directors of Zealand Pharma A/S
b) Initial notification/Amend
ment
Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc
tion monitor
a) Name Zealand Pharma A/S, CVR-no. 20045078
b) LEI1 549300ITBB1ULBL4CZ12
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type
of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial
instrument, type of instru
ment
Shares
Identification code DK0060257814
b) Nature of the transaction Sale of Shares
c) Price(s) and volume(s) Price(s) Volume(s)
DKK 218.70 575
d) Aggregated information
-
Aggregated volume
-
Price
575
125,753 DKK
e) Date of the transaction 19. April 2023
f) Place of the transaction Nasdaq Copenhagen

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

.

1. Details of the person discharging managerial responsibilities/person closely associated
a) Name Anneline Nansen
2. Reason for the notification
a) Position/status Employee elected member of the Board of Directors of Zealand Pharma A/S
b) Initial notification/Amend
ment
Initial notification
3. tion monitor Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc
a) Name Zealand Pharma A/S, CVR-no. 20045078
b) LEI1 549300ITBB1ULBL4CZ12
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type
of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial
instrument, type of instru
ment
Shares
Identification code DK0060257814
b) Nature of the transaction Sale of Shares
c) Price(s) and volume(s) Price(s) Volume(s)
DKK 218.70 2,060
d) Aggregated information
-
Aggregated volume
-
Price
2,060
450,522 DKK
e) Date of the transaction 19. April 2023
f) Place of the transaction Nasdaq Copenhagen

Talk to a Data Expert

Have a question? We'll get back to you promptly.